A hierarchical assembly method combines tumor lysis with a controlled expression of the immune effectors GM-CSF and interleukin (IL)-2, as well as single-chain variable fragments against the checkpoint inhibitors PD-1 or PD-L1. The gene discussed is CSF2; the disease is neoplasm.